Superstring Capital Management’s Century Therapeutics IPSC Stock Holding History

Superstring Capital Management’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$270K	Sell	119,308 -343,655	-74%	-$723K	0.19%	35
2025 Q4	$461K	Hold	462,963	–	–	0.25%	43
2025 Q3	$231K	Hold	462,963	–	–	0.23%	35
2025 Q2	$259K	Hold	462,963	–	–	0.31%	33
2025 Q1	$220K	Hold	462,963	–	–	0.26%	32
2024 Q4	$468K	Buy	+462,963	New	+$630K	0.4%	32

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Superstring Capital Management's IPSC Position: Q1 2026 in Review

Superstring Capital Management reduced its Century Therapeutics (IPSC) stake by 74% in Q1 2026, selling an estimated $723K and leaving 119,308 shares worth $270K. The position accounts for 0.19% of the portfolio, ranked #35.

Superstring Capital Management first reported a position in IPSC in Q4 2024 and has held it in 6 quarters since. The position peaked at $468K in Q4 2024. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

Superstring Capital Management held 119,308 shares of Century Therapeutics worth $270K as of Q1 2026.
Superstring Capital Management sold 343,655 Century Therapeutics shares in Q1 2026, an estimated $723K.
Century Therapeutics made up 0.19% of Superstring Capital Management's portfolio in Q1 2026, its #35 holding.
Superstring Capital Management first reported a position in Century Therapeutics in Q4 2024 and has held it in 6 quarters since.
Superstring Capital Management's Century Therapeutics position peaked at $468K in Q4 2024.
72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Superstring Capital Management's 13F filing for Q1 2026, filed 14 May 2026.